Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Experimental Study on the Use of Intrauterine Infusion of Autologous Platelet-rich Plasma (PRGF-IUI) in Patients With Recurrent Implantation Failure and/or Refractory Thin Endometrium [NA]

View source ↗

Summary

A clinical trial is evaluating intrauterine infusion of autologous platelet-rich plasma (PRP) for women with recurrent implantation failure and refractory thin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (autologous) (platelet-rich plasma)

Snippet

Sponsor: Azienda Sanitaria Locale di Asti | Conditions: Recurrent Implantation Failure, Endometrial Receptivity Disorders | NA | Status: NOT_YET_RECRUITING